arrow
U

Umberto Manera

azienda ospedaliero universitaria città della salute e della scienza
H指数:28
被引数:4,399

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recalibration of the Frontal Behavioural Inventory Cut-Off for Behavioural Screening in Amyotrophic Lateral Sclerosis

对额叶行为量表筛查肌萎缩侧索硬化症行为障碍的截断值进行重新校准

2026-10-070
OAAI
What do ALS motor phenotypes measure? A population-based decomposition of their prognostic dimensions

ALS运动表型测量的是什么?基于人群的预后维度的分解

2026-09-180
OAAI
Theory of mind impairment related to C9orf72 repeat expansion in amyotrophic lateral sclerosis: a case-control study

与C9orf72重复扩展相关的肌萎缩侧索硬化症中理论心智损害:一项病例对照研究

2026-08-240
OAAI
Toward a Behavioral Reserve Model in Amyotrophic Lateral Sclerosis

走向肌萎缩侧索硬化症的行为储备模型

2026-07-310
OAAI
King’s stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivity

肌萎缩侧索硬化症的King分期:基于18F-FDG-PET的大脑连接性研究

Brain
IF11.7
2026-05-080
OAAI
Machine learning model based on plasma proteomics for the identification of Parkinson’s disease

基于血浆蛋白质组学的帕金森病识别机器学习模型

Brain
IF11.7
2026-04-220
PRE
Factors associated with post-tracheostomy survival in Amyotrophic Lateral Sclerosis

与肌萎缩侧索硬化症气管切开术后生存相关的因素

2026-01-010
OAAI
Brain metabolic connectivity in ALS due to C9ORF72 hexanucleotide expansion: a [18F]FDG-PET study

ALS中由于C9ORF72六核苷酸重复扩展引起的脑代谢连接性:一项[18F]FDG-PET研究

2025-12-110
OAAI
The Epidemiology of Primary Lateral Sclerosis: Results from a Population-Based Cohort

原发性侧索硬化的流行病学:基于人群队列的研究结果

2025-11-280
OAAI
The BRAINTEASER Datasets: Clinical, Wearable and Environmental Data for ALS & MS Progression Modeling

BRAINTEASER数据集:用于ALS与MS进展建模的临床、可穿戴及环境数据

2025-11-210
OAAI
Role of 2-[18F]FDG-PET as a biomarker of upper motor neuron involvement in amyotrophic lateral sclerosis

2-[18F]FDG-PET作为上运动神经元在肌萎缩侧索硬化症中受累的生物标志物的角色

2025-11-170
OAAI
Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease

2040年肌萎缩侧索硬化症患病率预测:一种不那么罕见的疾病

2025-10-140
OAAI
Whole genome sequencing analysis in primary lateral sclerosis (PLS) patients reveals mutations in neurological diseases-causing genes

全基因组测序分析在原发性侧索硬化(PLS)患者中揭示了导致神经疾病的基因突变

2025-08-220
PRE
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis

基于血浆蛋白质组学的肌萎缩侧索硬化症预测候选生物标志物组合

2025-08-190
OA
Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohort

探索ANXA11变异体在ALS中的表型指纹:一项基于欧洲人群队列的研究

2025-07-210
OA
Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS study

呼吸功能、生存率及无创通气使用率随时间的变化——一项PRECISION ALS研究

2025-05-060
OA
Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALS

考察肌萎缩侧索硬化症(ALS)患者的职业状态变化及照护者协助情况,利用PRECISION-ALS研究中的大规模欧洲数据库。

2025-05-060
OA
Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant Study

修订版肌萎缩侧索硬化功能评分量表的自然病程及其与生存期的关联:PRECISION-ALS现况研究

2025-05-060
PRE
Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohort

绘制肌萎缩侧索硬化症的自然史:全欧洲、基于人群的PRECISION-ALS队列中临床里程碑的时间-事件分析

2025-05-060
OA
Real-world prognostic role of riluzole use in ALS: a multi-center study from PRECISION-ALS

利鲁唑在ALS中的真实世界预后作用:一项来自PRECISION-ALS的多中心研究

2025-05-060
OA